Leslie M. Magnus
Corporate Officer/Principal at SYNERGY PHARMACEUTICALS INC
Profile
Leslie M.
Magnus is currently the Senior Vice President-Medical Affairs at Synergy Pharmaceuticals LLC since 2015.
Previously, Magnus worked as the Vice President-Medical Affairs at UCB Pharma, Inc. Magnus completed an undergraduate degree at Brown University and a graduate degree at Albany State University (Georgia).
Leslie M. Magnus active positions
Companies | Position | Start |
---|---|---|
SYNERGY PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2015 |
Former positions of Leslie M. Magnus
Companies | Position | End |
---|---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Chief Tech/Sci/R&D Officer | - |
Training of Leslie M. Magnus
Brown University | Undergraduate Degree |
Albany State University (Georgia) | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Synergy Pharmaceuticals LLC
Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Leslie M. Magnus